Provided by Tiger Fintech (Singapore) Pte. Ltd.

CMS

13.350
-0.050-0.37%
Volume:3.47M
Turnover:45.98M
Market Cap:32.57B
PE:18.34
High:13.480
Open:13.250
Low:13.090
Close:13.400
52wk High:15.630
52wk Low:6.523
Shares:2.44B
HK Float Shares:2.44B
Volume Ratio:0.66
T/O Rate:0.14%
Dividend:0.30
Dividend Rate:2.23%
EPS(LYR):0.728
ROE:9.91%
ROA:5.58%
PB:1.75
PE(LYR):18.34
PS:3.80

Loading ...

China Medical System - Entered Into Two Seperate Exclusive Collaboration Agreements With Chongqing Genrix Biopharmaceutical

THOMSON REUTERS
·
Sep 22

China Medical System - Under Deals, Obtained Exclusive Commercialization Rights for Vecantoxatug and Silevimig Injections in Mainland China, Others

THOMSON REUTERS
·
Sep 22

CISI FIN Maintains "Buy" Rating for CMS, Exclusive and Innovative Products Drive New Growth

Stock News
·
Sep 16

China Medical System Holdings (SEHK:867) Reports Positive Earnings Growth for H1 2025

Simply Wall St.
·
Sep 12

Haitong International: Maintains "Outperform" Rating on CMS (00867) with Target Price of HK$18.38

Stock News
·
Sep 11

CITIC Securities Maintains "Buy" Rating for CMS (00867), Citing Innovation-Driven Long-Term Growth Potential

Stock News
·
Sep 09

Hong Kong Stock Market Analysis | Internal Restructuring Boosts Confidence as Giants Rally, Featured Stock SKYWORTH GROUP (00751) Surges at Market Close

Stock News
·
Sep 08

BRIEF-China Medical System Receives Approval For Clinical Trials Of Jak1 Inhibitor POVORCITINIB

Reuters
·
Aug 28

CMS (00867): Innovative Oral Small Molecule JAK1 Inhibitor Povorcitinib Receives Clinical Trial Approval for Vitiligo and Hidradenitis Suppurativa Indications

Stock News
·
Aug 28

China Medical System Holdings Limited Approval of Clinical Trials for Vitiligo and Hidradenitis Suppurativa Indications of Povorcitinib

THOMSON REUTERS
·
Aug 28

Dermavon Holdings, a Subsidiary of China Medical System, Gains Approval for Clinical Trials on Innovative JAK1 Inhibitor

Reuters
·
Aug 28

China Medical System Holdings Ltd - Nmpa Approves Clinical Trials for Povorcitinib

THOMSON REUTERS
·
Aug 28

CICC Maintains Outperform Rating on CMS (00867), Raises Target Price to HK$15.40

Stock News
·
Aug 20

Stock Track | CMS Soars 5% on Strong H1 2025 Results, Revenue and Profit Growth

Stock Track
·
Aug 19

CMS (867.HK, 8a8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers

THOMSON REUTERS
·
Aug 19

China Medical System Holdings Limited Cash Dividend/ Distribution

THOMSON REUTERS
·
Aug 18

CMS (00867) to Distribute Interim Dividend of HK$0.171 Per Share on September 9

Stock News
·
Aug 18

CMS (00867): Chen Hongbing Resigns as Non-Executive Director

Stock News
·
Aug 18

CMS (00867) Announces Interim Results with Attributable Profit of Approximately 941 Million Yuan, Up 3.38% Year-on-Year

Stock News
·
Aug 18

BRIEF-China Medical System Posts H1 Net Income Of RMB 931.5 Million

Reuters
·
Aug 18